title: Re: Pakravan et al.: Effect of early treatment with aqueous suppressants on Ahmed glaucoma valve implantation outcomes (Ophthalmology 2014;121:1693-8).
authors.affiliation: Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles.
authors.forename: Simon K
authors.initials: SK
authors.lastname: Law
authors.affiliation: Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles.
authors.forename: JoAnn A
authors.initials: JA
authors.lastname: Giaconi
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005901:Glaucoma / Q000628:therapy*; D020327:Glaucoma Drainage Implants; D006801:Humans; D008297:Male; D013449:Sulfonamides / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; D013999:Timolol